본문 바로가기

Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
SCIENTIFIC REPORTS10(1) · 2020
피인용
Web of Science 26Scopus 27
FWCI (Scopus)
0
JCR IF
JCR 2019 3.998
ISSN
2045-2322

저자

  1. Warner, Richard B.제1저자Department of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
  2. Najy, Abdo J.Department of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
  3. 정영석Department of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
  4. Fridman, RafaelDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
  5. Kim, SeonghoDepartment of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA
  6. Kim, Hyeong-Reh Choi교신저자Department of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA

초록

Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotropic protein, promoting both tumor-suppressive and tumor-promoting activities. While TIMP-1 is primarily known as an endogenous inhibitor of matrix metalloproteinases (MMPs) and thus associated with tumor cell invasion, clinical studies demonstrated increased expression of TIMP-1 and its association with poor prognosis in cancer. Non-MMP-inhibitory and oncogenic functions of TIMP-1 are mediated by induction of intracellular signaling via its cell surface receptor CD63, a tetraspanin. The present study investigates the structure-function relationship of TIMP-1 for its interaction with CD63, which may eventually help design a novel approach for targeting TIMP-1's pro-oncogenic activity without interfering its tumor suppressive MMP-inhibitory function. Importantly, our analysis includes TIMP-1/CD63 interactions at the cell surface of live cells. Here, we demonstrate that the 9 C-terminal amino acid residues of TIMP-1 and the large extracellular loop of CD63 are required for their interaction. Considering that the N-terminal half of TIMP-1 is sufficient for TIMP-1's MMP-inhibitory activity, we propose that those C-terminal amino acid residues are a potentially targetable motif of TIMP-1 oncogenic activity. As a proof of concept, we present the potential for the development of neutralizing antibodies against the C-terminal motif of TIMP-1 for disruption of TIMP-1 interaction with CD63 and the subsequent signal transduction.

키워드

BREAST EPITHELIAL-CELLSTIMP-1DEATHDIFFERENTIATIONDOMAINS

식별자

Scopus EID
2-s2.0-85079084076
WoS UID
000562828300016